The October 1 offering brought USD 110.0 million upfront. Pyxis Oncology stock has a USD 114.0 million market value on October 15, 2026. Pyxis Oncology secured USD 110.0 million in upfront gross ...
Maroussi, Greece - October 6, 2026 - Pyxis Tankers Inc. (Nasdaq Capital Market: PXS) (the "Company” or "Pyxis Tankers”), an international shipping company, announced today that it has agreed to a new ...
PhotoJoseph compares handheld walking and running footage, testing in-camera stabilization against gyro processing in DaVinci Resolve while examining cropping, smoothness, and motion blur. #LumixS1II ...
Pyxis Oncology (PYXS) lost more than 13% in premarket trading on Wednesday in reaction to the latest data from a Phase 1 study testing its lead candidate micvotabart pelidotin (MICVO) as a late-line ...
Pyxis Oncology has appointed Thomas Civik as Chief Executive Officer and Chairman of the Board, effective September 4, 2026, as the clinical-stage biotechnology company approaches several milestones ...
Solar panels cut Pyxis L's reliance on shore charging while a bespoke, air-conditioned interior transforms the traditional river bumboat into a venue for hosting. The solar-assisted Pyxis L on the ...
The solar-assisted Pyxis L on the Singapore River with Mr Ang Wee Keong (second from right), Chief Executive of the Maritime and Port Authority of Singapore Pyxis L was unveiled at a launch event at ...
Singapore, SINGAPORE, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Pyxis and Singapore River Cruise (SRC) today launched Pyxis L, a new passenger vessel that reimagines the traditional bumboat as a venue for ...
(Sharecast News) - Halma said it has agreed to acquire Pyxis, a US‑based specialist in water‑quality monitoring technology, in a deal worth an initial $170m (£126m). The FTSE‑100 firm added that ...
Halma PLC (LSE: HLMA) has agreed to acquire water quality monitoring specialist Pyxis for an initial $170 million (£126 million), strengthening its Environmental & Analysis division. The FTSE 100 ...
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Pyxis Oncology (NASDAQ:PYXS) with a Buy and maintains $7 price target. Wall Street analysts changed outlook on top names. For full changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results